Formulation Approaches | AIChE

Talks in this session will discuss approaches for accelerating clinical and commercial development by quickly developing phase appropriate formulations. Tools and approaches for rapid formulation development capable of predicting long-term stability should be emphasized. Other example topics include: the relationship of formulation to molecule selection/optimization, approaches for achieving high concentration formulations, and strategies to gain acceptable expiry by filing.


Session Co-Chairs:

  • John Carpenter, University of Colorado

  • Ping Yeh, Amgen


Confirmed Speakers

  • Vladimir Razinkov, Amgen: High Throughput Formulation Development of Therapeutic Proteins

  • David Volkin, University of Kansas: Utility of High-Throughput Biophysical Analysis of Protein Stability during Formulation Development and Comparability Assessments

  • Robert Mueller, Roche: Phase appropriate approach for formulation development